Novavax Covid Jab Highly Effective, But Not Against South Africa Variant

US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...

from NDTV News - Latest https://ift.tt/36lyTbO

Comments

Popular posts from this blog

"Modi Does What He Promises": PM On Why People Trust His 'Guarantees'

'800-Strong Mob Intended To Cause Death': Probe Agency On Bengal Attack